
Early zzso zzso and sequential systemic treatment, and hormonal therapy have benefits in treatment of breast zzso Management of zzso lung cancer zzso is progressing and will hopefully follow in the same footsteps as that of breast zzso Only recently have clinical trials established zzso treatment as the standard of care in lung zzso A growing number of effective zzso and targeted agents have resulted in increased survival when used as sequential treatment in both breast cancer and zzso The interaction between zzso receptors zzso in the lung and zzso growth factor zzso zzso suggests a potential role for zzso manipulation in the treatment of zzso This complex interaction involves several types of zzso receptors and different zzso zzso zzso between tobacco and zzso confound the effects of zzso zzso on risk of lung cancer, but not on that of breast zzso The optimum application of hormonal manipulation to prevent or treat lung cancer will depend on a zzso understanding of zzso zzso zzso Early trials have assessed the interaction between the zzso and zzso zzso 

